VIPoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{VIPoma}} {{CMG}} ==Overview== ==Epidemiology and Demographics== VIPoma is a rare (1 per 10,000,000 per year) endocrine tumor, usually (about 90%) originati..." |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
VIPoma is a rare (1 per 10,000,000 per year) [[endocrine]] [[tumor]], usually (about 90%) originating in the [[pancreas]], which produces [[vasoactive intestinal peptide]] (VIP). | VIPoma is a rare (1 per 10,000,000 per year) [[endocrine]] [[tumor]], usually (about 90%) originating in the [[pancreas]], which produces [[vasoactive intestinal peptide]] (VIP). VIPomas are usually diagnosed in adults, most commonly at age 50. Women are more likely to be affected than men. This cancer is rare, affecting an estimated 1 in 10 million people per year. | ||
==References== | ==References== | ||
Revision as of 01:16, 19 September 2012
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of VIPoma epidemiology and demographics |
|
Risk calculators and risk factors for VIPoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
VIPoma is a rare (1 per 10,000,000 per year) endocrine tumor, usually (about 90%) originating in the pancreas, which produces vasoactive intestinal peptide (VIP). VIPomas are usually diagnosed in adults, most commonly at age 50. Women are more likely to be affected than men. This cancer is rare, affecting an estimated 1 in 10 million people per year.